COVID-19 Vaccine Information

Saskatchewan has developed a COVID-19 Vaccine Delivery Plan, and will be ready to administer the vaccine when the first shipment is received.  Saskatchewan is working closely with the Public Health Agency of Canada (PHAC) which negotiates and procures vaccines directly with manufacturers on behalf of provinces and territories.  PHAC has established agreements with Astra Zeneca, Sanofi and GlaxoSmithKline, Novavax, Johnson & Johnson, Pfizer, Medicago, and Moderna to secure COVID-19 vaccines for Canadians. 

 

What Vaccines Have Been Approved?

Resource/Resource/Resource

On December 9, 2020, PHAC has approved The Pfizer-BioNTech COVID-19 mRNA vaccine (Tozinameran or BNT162b2). The vaccine is approved for people who are 16 years of age and older. Its safety and effectiveness in people younger than 16 years of age have not yet been established. Read more about how the Pfizer vaccine works.

The Moderna COVID-19 vaccine (mRNA-1273) is used to prevent COVID-19. This disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine is approved for people who are 18 years of age and older. Its safety and effectiveness in people younger than 18 years of age have not yet been established. Read more about how the Moderna vaccine works.

 

Saskatchewan's COVID-19 Vaccine Delivery Strategy

Resource

Saskatchewan will have a phased approach to the COVID-19 vaccine rollout, with the ability to scale up being possible in each phase. 

Pilot: December 15, 2020

  • Isolated pilot with 1,950 doses to immunize 1,950 health care workers in Regina working in ICUs, Emergency Departments, and COVID units at Regina General Hospital and Pasqua Hospitals.

Phase 1: Late December, 2020

  • Planned administration of 202,052 doses from the Pfizer vaccine. Moderna vaccine to be distributed to Northern and remote communities.
  • Targeted immunization of priority populations.
    • Priority populations include: health care workers, long-term care residents, and vulnerable populations. (please see the full vaccine delivery strategy for more detailed information)

Phase 2: Expected to begin April 2021

  • Continue to vaccinate priority populations.
  • Widespread access to immunization for the general population. Distribution to occur at clinics, physicians, nurse practitioners, and pharmacists.
  • Timing could occur earlier as vaccines are made available by PHAC.

 

Page Last Updated: 12/01/2021